Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan
Clinical Lung Cancer · 2026-07 · 27 (6) · 43-49
DOI: 10.1016/j.cllc.2026.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2026-07. Verfasst von Kazuya Takeda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan; Department of Radiation Oncology, South Miyag…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antibodies, Monoclonal, Chemoradiotherapy. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan; Department of Radiation Oncology, South Miyagi Medical Center, Shibata, Miyagi, Japan. Electronic address: kazuya.t…
- Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Takeda, K., Yamamoto, T., Umezawa, R., Takahashi, N., Okuda, S., & Jingu, K. (2026). Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan. Clinical Lung Cancer, 27(6), 43-49. https://doi.org/10.1016/j.cllc.2026.05.010
Vancouver
Takeda K, Yamamoto T, Umezawa R, Takahashi N, Okuda S, Jingu K. Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan. Clinical Lung Cancer. 2026;27(6):43-49. doi:10.1016/j.cllc.2026.05.010
BibTeX
@article{Takeda2026,
author = {Takeda, Kazuya and Yamamoto, Takaya and Umezawa, Rei and Takahashi, Noriyoshi and Okuda, Shinsaku and Jingu, Keiichi},
title = {Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC: A Real-World Analysis Using a Nationwide Claims Database in Japan},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {6},
pages = {43--49},
doi = {10.1016/j.cllc.2026.05.010}
}
EUVIMED